NCT07371988 Efficacy of Narrative Therapy for Older People With Depression
| NCT ID | NCT07371988 |
| Status | Recruiting |
| Phase | — |
| Sponsor | City University of Hong Kong |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2025-11-10 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2025-11-10 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The research aims to investigate the efficacy of a narrative therapy group in reducing depressive symptoms among older people. This study adopts a mixed methods research design, involving both quantitative and qualitative approaches. In the quantitative study, a randomised controlled trial will compare a narrative therapy group with a waitlist control group to determine whether an eight-session narrative therapy group can reduce depressive symptoms in older people. The eight-session narrative therapy group will be delivered by a trained and experienced social worker or counsellor, and intervention outcomes will be assessed before and after the intervention using a standardised assessment tool for depressive symptoms. The qualitative study aims to examine the benefits, advantages, and limitations of the narrative therapy group from the users' perspective.
Eligibility Criteria
Inclusion Criteria: 1. aged 60 years or above; 2. exhibiting depressive symptoms as assessed using a standardised assessment tool, namely the Chinese Beck Depression Inventory-II (BDI; Byrne et al., 2004), with a BDI score between 10 and 30; 3. being a service user of an elderly centre; and 4. providing informed consent to participate in this research. Exclusion Criteria: 1. Individuals with severe depression (i.e. a BDI score ≥ 31), dementia, psychosis, or self-reported suicidal thoughts are excluded from this study; and 2. Individuals currently receiving a therapeutic intervention are not excluded from this study.
Contact & Investigator
Kim-wan Daniel Young, PhD
PRINCIPAL INVESTIGATOR
City University of Hong Kong
Frequently Asked Questions
Who can join the NCT07371988 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07371988 currently recruiting?
Yes, NCT07371988 is actively recruiting participants. Contact the research team at dkwyoung@cityu.edu.hk for enrollment information.
Where is the NCT07371988 trial being conducted?
This trial is being conducted at Kowloon Tong, Hong Kong.
Who is sponsoring the NCT07371988 clinical trial?
NCT07371988 is sponsored by City University of Hong Kong. The principal investigator is Kim-wan Daniel Young, PhD at City University of Hong Kong. The trial plans to enroll 110 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.